Toggle light / dark theme

Imagine if your manager could know whether you actually paid attention in your last Zoom meeting. Or, imagine if you could prepare your next presentation using only your thoughts. These scenarios might soon become a reality thanks to the development of brain-computer interfaces (BCIs).

To put it in the simplest terms, think of a BCI as a bridge between your brain and an external device. As of today, we mostly rely on electroencephalography (EEG) — a collection of methods for monitoring the electrical activity of the brain — to do this. But, that’s changing. By leveraging multiple sensors and complex algorithms, it’s now becoming possible to analyze brain signals and extract relevant brain patterns. Brain activity can then be recorded by a non-invasive device — no surgical intervention needed. In fact, the majority of existing and mainstream BCIs are non-invasive, such as wearable headbands and earbuds.

The development of BCI technology was initially focused on helping paralyzed people control assistive devices using their thoughts. But new use cases are being identified all the time. For example, BCIs can now be used as a neurofeedback training tool to improve cognitive performance. I expect to see a growing number of professionals leveraging BCI tools to improve their performance at work. For example, your BCI could detect that your attention level is too low compared with the importance of a given meeting or task and trigger an alert. It could also adapt the lighting of your office based on how stressed you are, or prevent you from using your company car if drowsiness is detected.

One of the most remarkable recent advances in biomedical research has been the development of highly targeted gene-editing methods such as CRISPR that can add, remove, or change a gene within a cell with great precision. The method is already being tested or used for the treatment of patients with sickle cell anemia and cancers such as multiple myeloma and liposarcoma, and today, its creators Emmanuelle Charpentier and Jennifer Doudna received the Nobel Prize in chemistry.

While is remarkably precise in finding and altering genes, there is still no way to target treatment to specific locations in the body. The treatments tested so far involve removing or immune system T cells from the body to modify them, and then infusing them back into a patient to repopulate the bloodstream or reconstitute an immune response—an expensive and time-consuming process.

Building on the accomplishments of Charpentier and Doudna, Tufts researchers have for the first time devised a way to directly deliver gene-editing packages efficiently across the and into specific regions of the brain, into immune system cells, or to specific tissues and organs in mouse models. These applications could open up an entirely new line of strategy in the treatment of neurological conditions, as well as cancer, infectious disease, and autoimmune diseases.

A team of researchers from University Hospital Zurich and the University of Zurich, the Swiss Federal Institute of Technology and biotechnology company Philochem, has found fusing cytokines with antibodies to be an effective treatment for glioblastoma in mice. In their paper published in the journal Science Translational Medicine, the group describes their technique and how well it worked when tested with mouse models.

Glioblastoma is a type of cancerous brain tumor that is notoriously difficult to treat. Surgery to remove it is difficult and fraught with side effects, and drugs have little impact. In recent years, researchers have tried using drugs that alert the immune system to the presence of the tumor but they have not worked as hoped, either. In this new effort, the researchers tried another approach—fusing cytokines with antibodies as a way to attack the tumor. The hope was that together, the two would incite the immune system to attack the tumor more strongly and hopefully get rid of it.

Cytokines are small protein cells secreted by the immune system. Their usual job is to send signals to other cells in the immune system. And antibodies are Y-shaped proteins produced by , the workhorses of the that attack viruses and bacteria. In this new effort, the researchers fused L19 antibodies to cytokines. L19 was chosen because prior research has shown that it is able to seek out markers for glioblastoma. Fusing the two proteins together proved to be a more formidable therapeutic approach than using either alone. The resulting (L19TNF) immunocytokines were injected into mice with induced glioblastoma and were then monitored to determine their impact on the brain tumors.

Brains (mammalian, avian, reptilian) are analog, not digital/ hardwired for good evolutionary reasons (MVT). I have become interested in building synths recently — “Anyone with any passing interest in the synthesizer will have noticed not one, but three trends over the last decade. The first is a return to analogue… You can now get a phenomenal number of astounding synths — many of them ‘proper’ analogues — for an easy three digits. If you are as old as me, you’ll remember a time before when this was unthinkable. In fact, the whole idea of a return to analogue was unthinkable. “It would simply cost too much to (re) manufacture all of those analogue components,” they used to say, “and because everyone uses software, why would anyone be interested?”

Well, it turned out that analogue components could be cheap, and not everyone was interested in software (and if they were, they were also interested in hardware).”


Korg now has an analogue synth for every occasion. It’s time to meet the Minilogue XD, with even more sound design appeal, but still at a very keen price point.

Quantum mechanics arose in the 1920s, and since then scientists have disagreed on how best to interpret it. Many interpretations, including the Copenhagen interpretation presented by Niels Bohr and Werner Heisenberg, and in particular, von Neumann-Wigner interpretation, state that the consciousness of the person conducting the test affects its result. On the other hand, Karl Popper and Albert Einstein thought that an objective reality exists. Erwin Schrödinger put forward the famous thought experiment involving the fate of an unfortunate cat that aimed to describe the imperfections of quantum mechanics.

In their most recent article, Finnish civil servants Jussi Lindgren and Jukka Liukkonen, who study quantum mechanics in their free time, take a look at the that was developed by Heisenberg in 1927. According to the traditional of the principle, location and momentum cannot be determined simultaneously to an arbitrary degree of precision, as the person conducting the measurement always affects the values.

However, in their study Lindgren and Liukkonen concluded that the correlation between a location and momentum, i.e., their relationship, is fixed. In other words, reality is an object that does not depend on the person measuring it. Lindgren and Liukkonen utilized stochastic dynamic optimization in their study. In their theory’s frame of reference, Heisenberg’s uncertainty principle is a manifestation of thermodynamic equilibrium, in which correlations of random variables do not vanish.

Although it’s clearly NOT the approach taken for ultracold vitrification of patients undergoing life extension cryonization. (ULTRA🥶COLD being the exact opposite of ULTRA-BLOODY-H🥵T, obviously!)

Still, given the vast number of scientific and engineering discoveries and creations born on the backs of unexpected results, accidental discoveries, and outright screw up, it might have very useful data that has practical applications that would never otherwise have even been considered.


Italian scientists found intact brain cells in a man who was killed during the eruption of Mount Vesuvius in 79 AD.

Summary: Researchers have identified a network of genes in Zebrafish that regulate the process of determining whether certain neurons will regenerate.

Source: University of Notre Dame

The death of neurons, whether in the brain or the eye, can result in a number of human neurodegenerative disorders, from blindness to Parkinson’s disease. Current treatments for these disorders can only slow the progression of the illness, because once a neuron dies, it cannot be replaced.

Terms such as ‘Artificial Intelligence’ or ‘Neurotechnology’ were new some time not so long ago. We can’t evolve faster than our language does. We think in concepts and evolution itself is a linguistic, code-theoretic process. Do yourself a humongous favor, look over these 33 transhumanist neologisms. Here’s a fairly comprehensive glossary of thirty three newly-introduced concepts and terms from The Syntellect Hypothesis: Five Paradigms of the Mind’s Evolution by Russian-Amer… See More.

When we talk to someone from a different socioeconomic background, our brain reacts differently than when we address someone with a similar status to our own. Researchers found higher activity in the dorsolateral prefrontal cortex, an area of the brain associated with language and attentional control when people speak with those of different socioeconomic status. different socioeconomic background, our brain reacts differently than when we address someone with a similar status to our own. Researchers found higher activity in the dorsolateral prefrontal cortex, an area of the brain associated with language and attentional control when people speak with those of different socioeconomic status. different socioeconomic background our brain reacts differently than when we address someone with a similar status to our own. Researchers found higher activity in the dorsolateral prefrontal cortex, an area of the brain associated with language and attentional control when people speak with those of different socioeconomic status.

When the brain forms a memory of a new experience, neurons called engram cells encode the details of the memory and are later reactivated whenever we recall it. A new MIT study reveals that this process is controlled by large-scale remodeling of cells’ chromatin.

This remodeling, which allows involved in storing memories to become more active, takes place in multiple stages spread out over several days. Changes to the density and arrangement of chromatin, a highly compressed structure consisting of DNA and proteins called histones, can control how active specific genes are within a given cell.

“This paper is the first to really reveal this very mysterious process of how different waves of genes become activated, and what is the epigenetic mechanism underlying these different waves of gene expression,” says Li-Huei Tsai, the director of MIT’s Picower Institute for Learning and Memory and the senior author of the study.